Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3760/cma.j.cn112147-20200226-00191 http://scihub22266oqcxt.onion/10.3760/cma.j.cn112147-20200226-00191 33137863!?!33137863 Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=33137863&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215 Warning: Undefined variable $yww in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 538 Warning: Undefined variable $yww in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 538       Zhonghua+Jie+He+He+Hu+Xi+Za+Zhi 2020 ; 43 (11): 970-974 Nephropedia Template TP {{tp|p=33137863|t=2020. Potential therapeutic drugs for novel coronavirus pneumonia |pdf=|usr=}}{{33137863}} gab.com Text Potential therapeutic drugs for novel coronavirus pneumonia JO: Zhonghua Jie He He Hu Xi Za Zhi http://www.kidney.de/pget.php?&tw=1&pmid=33137863 #FOAvip The novel coronavirus pneumonia (COVID-19) is still in a serious situation. There is no specific therapeutic drug for COVID-19. At present, drugs, including lopinavir/ritonavir, chloroquine phosphate, abidol, IFN-alpha atomization and ribavirin, are commonly used in clinical practice. However, further clinical trials are needed to evaluate the efficacy and safety of these drugs. Other potential drugs that may be effective for COVID-19, are worthy of attention, including IL-6 monoclonal antibody, tyrosine protein kinase 1/2 inhibitor, cell therapy drugs, etc. This paper reviews these potential therapeutic drugs for COVID-19. Twit Text FOAVip Potential therapeutic drugs for novel coronavirus pneumonia ????Zhonghua Jie He He Hu Xi Za Zhi http://www.kidney.de/pget.php?&tw=1&pmid=33137863 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33137863 #FOAvip English Wikipedia <ref>{{Cite pmid|33137863}}</ref> Potential therapeutic drugs for novel coronavirus pneumonia #MMPMID33137863 Nie NF; He Y Zhonghua Jie He He Hu Xi Za Zhi 2020[Nov]; 43 (11): 970-974 PMID33137863show ga The novel coronavirus pneumonia (COVID-19) is still in a serious situation. There is no specific therapeutic drug for COVID-19. At present, drugs, including lopinavir/ritonavir, chloroquine phosphate, abidol, IFN-alpha atomization and ribavirin, are commonly used in clinical practice. However, further clinical trials are needed to evaluate the efficacy and safety of these drugs. Other potential drugs that may be effective for COVID-19, are worthy of attention, including IL-6 monoclonal antibody, tyrosine protein kinase 1/2 inhibitor, cell therapy drugs, etc. This paper reviews these potential therapeutic drugs for COVID-19. |Antiviral Agents/*therapeutic use[MESH] |Betacoronavirus[MESH] |COVID-19[MESH] |COVID-19 Drug Treatment[MESH] |Coronavirus Infections/*drug therapy[MESH] |Drug Combinations[MESH] |Humans[MESH] |Pandemics[MESH] |Pneumonia, Viral/*drug therapy[MESH] Potential therapeutic drugs for novel coronavirus pneumonia (epmc).pdf DeepDyve Pubget Overpricing